SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079256064> ?p ?o ?g. }

Showing items 1 to 89 of 89 with 100 items per page.

W2079256064 endingPage "539" @default.
W2079256064 startingPage "531" @default.
W2079256064 abstract "HomeCirculationVol. 59, No. 3Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBHemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. M Packer, J Meller, R Gorlin and M V Herman M PackerM Packer Search for more papers by this author , J MellerJ Meller Search for more papers by this author , R GorlinR Gorlin Search for more papers by this author and M V HermanM V Herman Search for more papers by this author Originally published1 Mar 1979https://doi.org/10.1161/01.CIR.59.3.531Circulation. 1979;59:531–539 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Xu M, Cao W, Xu X and Ji S (2018) Efficient synthesis of 2-arylquinazolin-4-amines via a copper-catalyzed diazidation and ring expansion cascade of 2-arylindoles , Chemical Communications, 10.1039/C8CC07721E, 54:89, (12602-12605) Cole R, Gheorghiade M, Georgiopoulou V, Gupta D, Marti C, Kalogeropoulos A and Butler J (2014) Reassessing the use of vasodilators in heart failure, Expert Review of Cardiovascular Therapy, 10.1586/erc.12.108, 10:9, (1141-1151), Online publication date: 1-Sep-2012. Cohn J (2007) The Medical Management of Heart Failure Cardiovascular Medicine, 10.1007/978-1-84628-715-2_66, (1397-1416), . STAESSEN J, LI Y, THIJS L and WANG J (2005) Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials, Hypertension Research, 10.1291/hypres.28.385, 28:5, (385-407), . Kieback A, Rödiger O, Jaenecke H, Grohmann A, Wernecke K, Baumann G and Felix S (2005) Hemodynamic Effects of α1-Adrenoceptor Antagonist, Doxazosin, in Patients With Chronic Congestive Heart Failure, Journal of Cardiovascular Pharmacology, 10.1097/01.fjc.0000175874.40543.b1, 46:4, (399-404), Online publication date: 1-Oct-2005. Kukin M (2007) The Most Important Issue: Use Beta Blockers, Congestive Heart Failure, 10.1111/j.1527-5299.2003.01945.x, 9:5, (251-254), Online publication date: 1-Sep-2003. Staessen J, Wang J and Thijs L (2003) Cardiovascular prevention and blood pressure reduction, Journal of Hypertension, 10.1097/00004872-200306000-00002, 21:6, (1055-1076), Online publication date: 1-Jun-2003. Kukin M (2008) Are All ß Blockers the Same for Heart Failure?, Congestive Heart Failure, 10.1111/j.1527-5299.2000.80149.x, 6:3, (153-157), Online publication date: 1-May-2000. Packer M (2000) Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure, American Heart Journal, 10.1016/S0002-8703(00)90074-7, 139:4, (S202-S206), Online publication date: 1-Apr-2000. Rapacciuolo A and Rockman H (2006) Role of β-Adrenoceptor Desensitization in Heart Failure, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1999.tb00027.x, 17:4, (384-394) Packer M (1998) β-adrenergic blockade in chronic heart failure: Principles, progress, and practice, Progress in Cardiovascular Diseases, 10.1016/S0033-0620(98)80030-3, 41:1, (39-52), Online publication date: 1-Jul-1998. Kukin M, Kalman J, Mannino M, Freudenberger R, Buchholz C and Ocampo O (1996) Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure, The American Journal of Cardiology, 10.1016/S0002-9149(97)89342-3, 77:7, (486-491), Online publication date: 1-Mar-1996. Hui S and Qiu B (1996) Influence of repeated prazosin administration on cardiovascular responses in rats and rabbits, Experientia, 10.1007/BF01922418, 52:1, (66-69), Online publication date: 1-Jan-1996. Cohn J (2009) Left Ventricular Dysfunction and Heart Failure Mechanistic and Therapeutic Distinctions, Clinical and Experimental Hypertension, 10.3109/10641969609088985, 18:3-4, (559-568), Online publication date: 1-Jan-1996. Cockcroft J, O'Kane K and Webb D (1995) Tissue angiotensin generation and regulation of vascular tone, Pharmacology & Therapeutics, 10.1016/0163-7258(94)00062-8, 65:2, (193-213), Online publication date: 1-Jan-1995. Feng Q and Arnold J (1995) Vascular α-Adrenergic Function in Congestive Heart Failure Mechanisms of Heart Failure, 10.1007/978-1-4615-2003-0_4, (37-50), . Crozier I, Ikram H, Awan N, Cleland J, Stephen N, Dickstein K, Frey M, Young J, Klinger G, Makris L and Rucinska E (1995) Losartan in Heart Failure, Circulation, 10.1161/01.CIR.91.3.691, 91:3, (691-697), Online publication date: 1-Feb-1995. Horn E, Kukin M, Neuberg G, Goldsmith R, McCarty M, Gratch M, Medina N, Yushak M, Packer M and Bilezikian J (1995) Lymphocyte G proteins reflect response to treatment in congestive heart failure, American Heart Journal, 10.1016/0002-8703(95)90049-7, 129:1, (98-106), Online publication date: 1-Jan-1995. Haas G and Leier C (1994) Vasodilators Congestive Heart Failure, 10.1007/978-1-4613-8315-4_24, (400-453), . Metra M, Nardi M, Giubbini R and Cas L (1994) Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy, Journal of the American College of Cardiology, 10.1016/0735-1097(94)90174-0, 24:7, (1678-1687), Online publication date: 1-Dec-1994. Ogino K, Noguchi N, Osaki S, Kitamura H, Matsumoto T, Kato M, Kinugawa T, Miyakoda H, Kotake H, Mashiba H, Kasahara T and Endo S (1993) Acute hemodynamic effects of bunazosin in congestive heart failure—Differing responses according to degree of cardiac dysfunction, General Pharmacology: The Vascular System, 10.1016/0306-3623(93)90167-V, 24:4, (899-904), Online publication date: 1-Jul-1993. Pfeffer M (1993) Angiotensin-converting enzyme inhibition in congestive heart failure: Benefit and perspective, American Heart Journal, 10.1016/0002-8703(93)90931-X, 126:3, (789-793), Online publication date: 1-Sep-1993. Dietz R (1992) Therapie — Vasodilatierende Substanzen Herzinsuffizienz, 10.1007/978-3-642-77021-0_18, (181-191), . Kradjan W (1992) Congestive Heart Failure Applied Therapeutics, 10.1007/978-1-349-13175-4_9, (135-171), . Dietz R (1992) Therapie — Behandlung früher und heute (Stufenplan) Herzinsuffizienz, 10.1007/978-3-642-77021-0_20, (203-213), . Kukin M (1992) Vasodilator therapy and survival in chronic congestive heart failure, Journal of the American College of Cardiology, 10.1016/0735-1097(92)90345-N, 19:6, (1360-1362), Online publication date: 1-May-1992. Munger M, Chance M, Nair R, Prescott A, Nara A, Simonson M, Green J and Posvar E (2013) Evaluation of Quinapril on Regional Blood Flow and Cardiac Function in Patients with Congestive Heart Failure, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1992.tb03791.x, 32:1, (70-76), Online publication date: 1-Jan-1992. DiBianco R, Parker J, Chakko S, Tanser P, Emmanuel G, Singh J and Marlon A (1991) Doxazosin for the treatment of chronic congestive heart failure: Results of a randomized double-blind and placebo-controlled study, American Heart Journal, 10.1016/0002-8703(91)90875-I, 121:1, (372-380), Online publication date: 1-Jan-1991. Markus H and Cowley A (1991) The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure, European Journal of Clinical Pharmacology, 10.1007/BF00279964, 40:6, (535-538), Online publication date: 1-Jun-1991. Bartels G, Remme W, Wiesfeld A, Kok F, Look M, Krauss X and Kruyssen H (1990) Duration and reproducibility of initial hemodynamic effects of flosequinan in patients with congestive heart failure, Cardiovascular Drugs and Therapy, 10.1007/BF01856558, 4:3, (705-712), Online publication date: 1-May-1990. Silke B, Zezulka A, Verma S, Tham T and Taylor S (2012) Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1990.tb03697.x, 29:6, (749-758), Online publication date: 1-Jun-1990. Munger M, Gardner S and Jarvis R (2016) Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure, Journal of Pharmacy Practice, 10.1177/089719009000300506, 3:5, (318-331), Online publication date: 1-Oct-1990. The SOLVD Investigators (1990) Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction, The American Journal of Cardiology, 10.1016/0002-9149(90)90842-O, 66:3, (315-322), Online publication date: 1-Aug-1990. Tanio H, Kumada T, Kihara Y, Miyazaki S, Hayashi M, Himura Y, Kanbayashi M, Hayashida W, Nakamura Y and Kawai C (1990) Direct Measurement of Aortic and Vena Caval Flow to Evaluate the Effect of Vasodilators in Experimental Acute mitral regurgitation Biofluid Mechanics, 10.1007/978-3-642-52338-0_10, (91-100), . Ikram H and Crozier I (1990) Xamoterol in severe heart failure, The Lancet, 10.1016/0140-6736(90)92078-V, 336:8713, (517-518), Online publication date: 1-Aug-1990. Mirvis D, Insel J, Boland M, Cinquegrani M, Ghali J, Rubin S, Shanes J, DeSilva J and Whalen J (1990) Chronic Therapy for Congestive Heart Failure with Benazepril HCl, a New Angiotensin Converting Enzyme Inhibitor, The American Journal of the Medical Sciences, 10.1097/00000441-199012000-00003, 300:6, (354-360), Online publication date: 1-Dec-1990. Lang R (1990) Medical management of chronic heart failure: Inotropic, vasodilator, or inodilator drugs?, American Heart Journal, 10.1016/0002-8703(90)90059-7, 120:6, (1558-1564), Online publication date: 1-Dec-1990. Reindell H, Roskamm H, Barmeyer J, Eichstädt H, Bubenheimer P, Gohlke-Bärwolf C and Gohlke H (1989) Mitralinsuffizienz Herzkrankheiten, 10.1007/978-3-642-97060-3_52, (1218-1244), . Kannel W and Carter B (1989) Initial drug therapy for hypertensive patients with hyperlipidemia, American Heart Journal, 10.1016/0002-8703(89)90237-8, 118:5, (1012-1021), Online publication date: 1-Nov-1989. Brilla C, Krämer B, Hoffmeister H, Müller-Schauenburg W, Risler T and Seipel L (1989) Low-dose enalapril in severe chronic heart failure, Cardiovascular Drugs and Therapy, 10.1007/BF01883867, 3:2, (211-218), Online publication date: 1-Mar-1989. Franciosa J and Schwartz D (1989) Acute hemodynamic effects of norepinephrine inhibition in patients with severe chronic congestive heart failure, Journal of the American College of Cardiology, 10.1016/0735-1097(89)90103-4, 14:3, (624-630), Online publication date: 1-Sep-1989. Gifford R (1989) Management of hypertensive patients with cardiac problems The Heart in Hypertension, 10.1007/978-94-009-0941-0_21, (221-239), . Geltman E (1989) Mild heart failure: Diagnosis and treatment, American Heart Journal, 10.1016/0002-8703(89)90020-3, 118:6, (1277-1291), Online publication date: 1-Dec-1989. Chatterjee K (1989) Digitalis and Non-ACE Inhibitor Vasodilators in Heart Failure, Cardiology Clinics, 10.1016/S0733-8651(18)30460-0, 7:1, (99-118), Online publication date: 1-Feb-1989. Remme W (1989) Vasodilator therapy without converting-enzyme inhibition in congestive heart failure—Usefulness and limitations, Cardiovascular Drugs and Therapy, 10.1007/BF01858109, 3:3, (375-396), Online publication date: 1-May-1989. Massie B (1988) New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure, The American Journal of Medicine, 10.1016/0002-9343(88)90468-8, 84:4, (36-46), Online publication date: 1-Apr-1988. Tweddel A, Martin W, McGhie A and Hutton I (2012) Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1988.tb05254.x, 25:6, (689-694), Online publication date: 1-Jun-1988. Baker B (1988) Dilated Cardiomyopathy: The Role of the Right Ventricle in Determining Functional Capacity The Right Ventricle, 10.1007/978-1-4613-1773-9_7, (131-140), . Packer M (1988) Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope, Journal of the American College of Cardiology, 10.1016/0735-1097(88)92615-0, 12:5, (1299-1317), Online publication date: 1-Nov-1988. Greenberg B (1988) Vasodilator Therapy of Chronic Aortic Regurgitation Chronic Aortic Regurgitation, 10.1007/978-1-4613-1729-6_8, (143-159), . Greenberg B, Siemienczuk D and Broudy D (1988) Isradipine improves cardiac function in congestive heart failure, The American Journal of Medicine, 10.1016/0002-9343(88)90189-1, 84:3, (56-61), Online publication date: 1-Mar-1988. Massie B (1988) New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure, The American Journal of Medicine, 10.1016/S0002-9343(88)80166-9, 84, (36-46), Online publication date: 1-Apr-1988. Frishman W, Eisen G and Lapsker J (1988) Terazosin: A New Long-Acting α1-Adrenergic Antagonist for Hypertension, Medical Clinics of North America, 10.1016/S0025-7125(16)30778-7, 72:2, (441-448), Online publication date: 1-Mar-1988. Leier C, Majetich N, Binkley P and Unverferth D (2012) Hemodynamic Responses to Indoramin at Rest and During Exercise in Congestive Heart Failure, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.1987.tb03519.x, 7:3, (61-68), Online publication date: 6-May-1987. Schneeweiss A and Schettler G (1987) Prazosin Cardiovascular Drug Therapy in the Elderly, 10.1007/978-1-4613-2063-0_16, (145-155), . Cohn J (1987) Status of Vasodilators for Heart Failure Congestive Heart Failure, 10.1007/978-1-4613-2077-7_14, (187-192), . Goldsmith S (2016) Treatment of congestive heart failure, Postgraduate Medicine, 10.1080/00325481.1987.11699878, 81:8, (257-268), Online publication date: 1-Jun-1987. Kopecky S and Gersh B (1987) Dilated cardiomyopathy and myocarditis: Natural history, etiology, clinical manifestations, and management, Current Problems in Cardiology, 10.1016/0146-2806(87)90002-8, 12:10, (574-647), Online publication date: 1-Oct-1987. Greenberg B, Siemienczuk D and Broudy D (1987) Hemodynamic effects of PN 200-110 (isradipine) in congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(87)90085-3, 59:3, (B70-B74), Online publication date: 1-Jan-1987. Leier C, Binkley P, Huss Randolph P and Unverferth D (1987) Long-term indoramin therapy in congestive heart failure: A double-blind, randomized, parallel placebo-controlled trial, Journal of the American College of Cardiology, 10.1016/S0735-1097(87)80399-6, 9:2, (426-432), Online publication date: 1-Feb-1987. Kessler P and Packer M (1987) Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure, American Heart Journal, 10.1016/0002-8703(87)90021-4, 113:1, (137-143), Online publication date: 1-Jan-1987. Alpert M (2016) Pharmacotherapy of congestive heart failure, Postgraduate Medicine, 10.1080/00325481.1987.11699832, 81:6, (257-267), Online publication date: 1-May-1987. Riegger G, Haeske W, Kraus C, Kromer E and Kochsiek K (1987) Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment, The American Journal of Cardiology, 10.1016/0002-9149(87)91117-9, 59:8, (906-910), Online publication date: 1-Apr-1987. Leier C, Patterson S, Huss P, Parrish D and Unverferth D (1986) The Hemodynamic and Clinical Responses to Terazosin, a New α Blocking Agent, in Congestive Heart Failure, The American Journal of the Medical Sciences, 10.1097/00000441-198609000-00002, 292:3, (128-135), Online publication date: 1-Sep-1986. Silber S, Hany F, Weber M, Theisen K and Jahrmärker H (1986) Wirkung des selektiven Alpha1-Blockers Urapidil auf die Hämodynamik von Patienten mit chronischer Herzinsuffizienz ohne arterielle Hypertonie Vasoaktive Substanzen bei Herzinsuffizienz, 10.1007/978-3-642-71486-3_13, (101-111), . Francis G and Cohn J (1986) Afterload Reduction Topics in Clinical Pharmacology and Therapeutics, 10.1007/978-1-4612-4864-4_6, (135-150), . Greenbaum R, Wan S and Evans T (1986) The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure, European Journal of Clinical Pharmacology, 10.1007/BF00607948, 30:4, (383-386), . Packer M (1986) Utility of Prazosin in the Management of Patients with Severe Chronic Congestive Heart Failure Vasoaktive Substanzen bei Herzinsuffizienz, 10.1007/978-3-642-71486-3_15, (125-127), . Creager M, Faxon D, Cutler S, Kohlmann O, Ryan T and Gavras H (1986) Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system, Journal of the American College of Cardiology, 10.1016/S0735-1097(86)80333-3, 7:4, (758-765), Online publication date: 1-Apr-1986. Lorimer A and Hillis W (1985) Cardiac Failure Cardiovascular Disease, 10.1007/978-1-4471-3120-5_9, (151-174), . Bussmann W (1986) Prazosin in Chronic Heart Failure Acute and Chronic Heart Failure, 10.1007/978-3-642-61627-3_20, (235-251), . Wahr D and Chatterjee K (1986) Hemodynamic Consequences of Myocardial Infarction and the Role of Vasodilators in Acute and Chronic Management The Pathophysiology and Pharmacotherapy of Myocardial Infarction, 10.1016/B978-0-12-238045-7.50008-X, (39-84), . WESTHEIM A, KOSS A and SIVERTSSEN E (2009) Hemodynamic Effects at Rest and during Exercise in Long-term Treatment with Prazosin in Chronic Congestive Heart Failure, Acta Medica Scandinavica, 10.1111/j.0954-6820.1986.tb03338.x, 219:5, (449-453) Reifart N, Nadj M, Kaltenbach M and Bussmann W (1986) Langzeitwirkung von Prazosin bei chronischer Herzinsuffizienz in einer doppelblind randomisierten Untersuchung über ein Jahr Vasoaktive Substanzen bei Herzinsuffizienz, 10.1007/978-3-642-71486-3_14, (112-124), . Sutton F (1986) Vasodilator therapy, The American Journal of Medicine, 10.1016/0002-9343(86)90146-4, 80:2, (54-58), Online publication date: 1-Feb-1986. Cohn J, Archibald D, Ziesche S, Franciosa J, Harston W, Tristani F, Dunkman W, Jacobs W, Francis G, Flohr K, Goldman S, Cobb F, Shah P, Saunders R, Fletcher R, Loeb H, Hughes V and Baker B (1986) Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure, New England Journal of Medicine, 10.1056/NEJM198606123142404, 314:24, (1547-1552), Online publication date: 12-Jun-1986. Ruggie N (1986) Congestive Heart Failure, Medical Clinics of North America, 10.1016/S0025-7125(16)30927-0, 70:4, (829-851), Online publication date: 1-Jul-1986. Packer M, Medina N and Yushak M (1986) Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(86)80479-X, 7:3, (671-680), Online publication date: 1-Mar-1986. Mettauer B, Rouleau J, Bichet D, Kortas C, Manzini C, Tremblay G and Chatterjee K (1986) Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity., Circulation, 73:3, (492-502), Online publication date: 1-Mar-1986.Lee W and Packer M (1986) Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure., Circulation, 73:2, (257-267), Online publication date: 1-Feb-1986. Timmis A, Smyth P and Jewitt D (1985) Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment., Heart, 10.1136/hrt.54.1.42, 54:1, (42-47), Online publication date: 1-Jul-1985. Uretsky B, Generalovich T, Verbalis J, Valdes A and Sudhakar Reddy P (1985) MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response, Journal of the American College of Cardiology, 10.1016/S0735-1097(85)80358-2, 5:6, (1414-1421), Online publication date: 1-Jun-1985. Francis G (1985) Neurohumoral mechanisms involved in congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(85)90791-X, 55:2, (A15-A21), Online publication date: 1-Jan-1985. Mettauer B, Rouleau J and Burgess J (1985) Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure, American Heart Journal, 10.1016/0002-8703(85)90648-9, 109:4, (840-847), Online publication date: 1-Apr-1985. Jackson C and McNeill J (1985) Smooth Muscle Relaxants Calcium and Contractility, 10.1007/978-1-4612-5172-9_5, (119-141), . Petru M, Crawford M, Kennedy G, Amon K and O'Rourke R (1985) Long-term efficacy of high-dose diltiazem for chronic stable angina pectoris: 16-month serial studies with placebo controls, American Heart Journal, 10.1016/0002-8703(85)90422-3, 109:1, (99-103), Online publication date: 1-Jan-1985. Butman S, Eagan J and Olson H (1985) Hemodynamic effects of verapamil in left ventricular valvular volume overload, American Heart Journal, 10.1016/0002-8703(85)90165-6, 110:2, (416-426), Online publication date: 1-Aug-1985. Chatterjee K (1985) Recent Advances in the Management of Chronic Heart Failure, Primary Care: Clinics in Office Practice, 10.1016/S0095-4543(21)01244-6, 12:1, (117-142), Online publication date: 1-Mar-1985. Sponer G, Mierzwa E, Strein K and Müller-Beckmann B (1985) Activation of Counter-Regulatory Mechanisms on Administration of Equipotent Doses of Different Types of Vasodilators to Conscious Dogs Mononitrates, 10.1007/978-3-642-70234-1_7, (39-44), . Friedman W and George B (1985) Treatment of congestive heart failure by altering loading conditions of the heart, The Journal of Pediatrics, 10.1016/S0022-3476(85)80339-5, 106:5, (697-706), Online publication date: 1-May-1985. Jordan R, Seith L, Henry D, Wilen M and Franciosa J (1985) Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure., Circulation, 71:5, (980-986), Online publication date: 1-May-1985. Firth B (1984) Chronic Congestive Heart Failure—The Nature of the Problem and Its Management in 1984, The American Journal of the Medical Sciences, 10.1097/00000441-198411000-00006, 288:4, (178-192), Online publication date: 1-Nov-1984. Horowitz J, Dynon M, Jarrott B, Brennan J, Oliver L, Goble A and Louis W (1984) HAEMODYNAMIC EFFECTS OF A SINGLE LOW DOSE OF PRAZOSIN IN PATIENTS WITH CHRONIC CONGESTIVE CARDIAC FAILURE CORRELATIONS WITH PHARMACOKINETICS, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.1984.tb00234.x, 11:1, (7-15), Online publication date: 1-Feb-1984. Friedman W and George B (1984) New Concepts and Drugs in the Treatment of Congestive Heart Failure, Pediatric Clinics of North America, 10.1016/S0031-3955(16)34717-4, 31:6, (1197-1227), Online publication date: 1-Dec-1984. Bussmann W (1984) Der Einsatz von Vasodilatatoren bei chronischer Herzinsuffizienz Herzinsuffizienz, 10.1007/978-3-642-82183-7_16, (657-718), . Cohn J (1984) Unloading the Heart in Congestive Heart Failure, The American Journal of Medicine, 10.1016/S0002-9343(84)80060-1, 77:2, (67-70), Online publication date: 1-Aug-1984. Sjögren A (2009) Treatment of congestive heart failure, Acta Pharmacologica et Toxicologica, 10.1111/j.1600-0773.1984.tb03640.x, 54, (93-101) Kjekshus J (2016) Ace Inhibitors in Heart Failure, Scandinavian Journal of Urology and Nephrology, 10.1080/00365599.1984.11783728, 18:sup79, (115-120), Online publication date: 1-Jul-1984. Erdmann E (1984) Therapie der akuten und chronischen Herzinsuffizienz mit Herzglykosiden Herzinsuffizienz, 10.1007/978-3-642-82183-7_15, (563-656), . Franciosa J, Dunkman W and Leddy C (1984) Hemodynamic effects of vasodilators and long-term response in heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(84)80292-2, 3:6, (1521-1530), Online publication date: 1-Jun-1984. Dubourg O, Gueret P, Ferrier A, Farcot J, Terdjman M, Rigaud M, Beaumont D, Bardet J and Bourdarias J (1984) Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure, European Journal of Clinical Pharmacology, 10.1007/BF00542156, 27:3, (259-263), . Sharpe D, Murphy J, Coxon R and Hannan S (1984) Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study., Circulation, 70:2, (271-278), Online publication date: 1-Aug-1984. Jebavý P, Koudelková E and Henzlová M (1983) Unloading effects of prazosin in patients with chronic aortic regurgitation, American Heart Journal, 10.1016/0002-8703(83)90479-9, 105:4, (567-574), Online publication date: 1-Apr-1983. Franciosa J (1983) Fehlende Toleranz gegenüber den hämodynamischen Wirkungen von Nitraten bei Patienten mit chronischer Herzinsuffizienz Nitrate und Nitrattoleranz in der Behandlung der koronaren Herzerkrankung, 10.1007/978-3-662-12598-4_4, (35-42), . Quyyumi A, Wagstaff D and Evans T (1983) Acute hemodynamic effects of endralazine: A new vasodilator for chronic refractory congestive heart failure, The American Journal of Cardiology, 10.1016/0002-9149(83)90311-9, 51:8, (1353-1357), Online publication date: 1-May-1983. Erdmann E (1983) Alternativen zur Herzglykosidtherapie Therapie mit Herzglykosiden, 10.1007/978-3-642-69046-4_11, (128-134), . Higginbotham M, Morris K, Bramlet D, Coleman R and Cobb F (1983) Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: Relation between clinical response and left ventricular function at rest and during exercise, The American Journal of Cardiology, 10.1016/0002-9149(83)90415-0, 52:7, (782-788), Online publication date: 1-Oct-1983. Chatterjee K and Parmley W (1983) Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80018-7, 1:1, (133-153), Online publication date: 1-Jan-1983. Oates J, Robertson D, Wood A and Woosley R (1983) Alpha- and beta-adrenergic agonists and antagonists Cardiac therapy, 10.1007/978-1-4613-3855-0_6, (145-169), . Markham R, Corbett J, Gilmore A, Pettinger W and Firth B (1983) Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind, placebo-controlled study, The American Journal of Cardiology, 10.1016/0002-9149(83)90310-7, 51:8, (1346-1352), Online publication date: 1-May-1983. Dawson J, Canepa-Anson R, Kuan P, Reuben S, Poole-Wilson P and Sutton G (1983) Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol., Heart, 10.1136/hrt.50.3.282, 50:3, (282-289), Online publication date: 1-Sep-1983. Prida X, Kubo S, Laragh J and Cody R (1983) Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure, The American Journal of Medicine, 10.1016/0002-9343(83)90410-2, 75:5, (795-800), Online publication date: 1-Nov-1983. Packer M (1983) New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure, The American Journal of Medicine, 10.1016/0002-9343(83)90856-2, 74:6, (61-72), Online publication date: 1-Jun-1983. Packer M (1983) Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism, Journal of the American College of Cardiology, 10.1016/S0735-1097(83)80230-7, 2:5, (841-852), Online publication date: 1-Nov-1983. Gould L, Gopalaswamy C, Chandy F and Abdou O (2016) Noninvasive Assessment of Left Ventricular Wall Stress in Chronic Congestive Heart Failure Patients, Angiology, 10.1177/000331978303400205, 34:2, (111-118), Online publication date: 1-Feb-1983. Franciosa J (1983) Lack of Tolerance Development to the Hemodynamic Effects of Nitrates in Patients with Chronic Congestive Heart Failure Nitrates and Nitrate Tolerance in Angina Pectoris, 10.1007/978-3-642-85323-4_4, (35-42), . Williams E and Fisch C (1983) Treatment of cardiac failure Cardiac therapy, 10.1007/978-1-4613-3855-0_14, (453-479), . Nies A and Neufeld G (1983) The pharmacolgy of vasodilator and antianginal drugs Cardiac therapy, 10.1007/978-1-4613-3855-0_13, (435-451), . Wenting G, Man in't veld A, Woittiez A, Boomsma F, Laird-Meeter K, Simoons M, Hugenholtz P and Schalekamp M (1983) Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone., Heart, 10.1136/hrt.49.1.65, 49:1, (65-76), Online publication date: 1-Jan-1983. Uretsky B, Generalovich T, Reddy P, Spangenberg R and Follansbee W (1983) The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure., Circulation, 67:4, (823-828), Online publication date: 1-Apr-1983.Kramer B, Massie B and Topic N (1983) Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study., Circulation, 67:4, (807-816), Online publication date: 1-Apr-1983.Packer M, Medina N, Yushak M and Meller J (1983) Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure., Circulation, 68:4, (803-812), Online publication date: 1-Oct-1983. Walsh W and Lee C (2012) Acute and chronic effects of captopril therapy in patients with refractory heart failure., British Journal of Clinical Pharmacology, 10.1111/j.1365-2125.1982.tb02072.x, 14:S2, (153S-159S), Online publication date: 1-Apr-1982. Heagerty A, Russell G, Bing R, Thurston H and Swales J (2012) The addi" @default.
W2079256064 created "2016-06-24" @default.
W2079256064 creator A5034380498 @default.
W2079256064 creator A5042766753 @default.
W2079256064 creator A5072086322 @default.
W2079256064 creator A5079145274 @default.
W2079256064 date "1979-03-01" @default.
W2079256064 modified "2023-09-24" @default.
W2079256064 title "Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure." @default.
W2079256064 cites W1968668094 @default.
W2079256064 cites W1970580461 @default.
W2079256064 cites W1975525940 @default.
W2079256064 cites W1979933589 @default.
W2079256064 cites W1996316222 @default.
W2079256064 cites W2002854148 @default.
W2079256064 cites W2003376830 @default.
W2079256064 cites W2009962011 @default.
W2079256064 cites W2016907029 @default.
W2079256064 cites W2019283770 @default.
W2079256064 cites W2020239960 @default.
W2079256064 cites W2020256998 @default.
W2079256064 cites W2020621798 @default.
W2079256064 cites W2032278417 @default.
W2079256064 cites W2034007043 @default.
W2079256064 cites W2047179470 @default.
W2079256064 cites W2074817505 @default.
W2079256064 cites W2089353223 @default.
W2079256064 cites W2110726094 @default.
W2079256064 cites W2155255806 @default.
W2079256064 cites W2315615479 @default.
W2079256064 cites W2331058240 @default.
W2079256064 cites W2411128698 @default.
W2079256064 doi "https://doi.org/10.1161/01.cir.59.3.531" @default.
W2079256064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/761333" @default.
W2079256064 hasPublicationYear "1979" @default.
W2079256064 type Work @default.
W2079256064 sameAs 2079256064 @default.
W2079256064 citedByCount "225" @default.
W2079256064 countsByYear W20792560642012 @default.
W2079256064 countsByYear W20792560642018 @default.
W2079256064 countsByYear W20792560642023 @default.
W2079256064 crossrefType "journal-article" @default.
W2079256064 hasAuthorship W2079256064A5034380498 @default.
W2079256064 hasAuthorship W2079256064A5042766753 @default.
W2079256064 hasAuthorship W2079256064A5072086322 @default.
W2079256064 hasAuthorship W2079256064A5079145274 @default.
W2079256064 hasBestOaLocation W20792560641 @default.
W2079256064 hasConcept C123576724 @default.
W2079256064 hasConcept C126322002 @default.
W2079256064 hasConcept C164705383 @default.
W2079256064 hasConcept C168481208 @default.
W2079256064 hasConcept C170493617 @default.
W2079256064 hasConcept C178853913 @default.
W2079256064 hasConcept C2776885963 @default.
W2079256064 hasConcept C2778198053 @default.
W2079256064 hasConcept C2780648677 @default.
W2079256064 hasConcept C71924100 @default.
W2079256064 hasConceptScore W2079256064C123576724 @default.
W2079256064 hasConceptScore W2079256064C126322002 @default.
W2079256064 hasConceptScore W2079256064C164705383 @default.
W2079256064 hasConceptScore W2079256064C168481208 @default.
W2079256064 hasConceptScore W2079256064C170493617 @default.
W2079256064 hasConceptScore W2079256064C178853913 @default.
W2079256064 hasConceptScore W2079256064C2776885963 @default.
W2079256064 hasConceptScore W2079256064C2778198053 @default.
W2079256064 hasConceptScore W2079256064C2780648677 @default.
W2079256064 hasConceptScore W2079256064C71924100 @default.
W2079256064 hasIssue "3" @default.
W2079256064 hasLocation W20792560641 @default.
W2079256064 hasLocation W20792560642 @default.
W2079256064 hasOpenAccess W2079256064 @default.
W2079256064 hasPrimaryLocation W20792560641 @default.
W2079256064 hasRelatedWork W116405568 @default.
W2079256064 hasRelatedWork W133119128 @default.
W2079256064 hasRelatedWork W2079256064 @default.
W2079256064 hasRelatedWork W2139544470 @default.
W2079256064 hasRelatedWork W2381693144 @default.
W2079256064 hasRelatedWork W2736076578 @default.
W2079256064 hasRelatedWork W3137078751 @default.
W2079256064 hasRelatedWork W3145098517 @default.
W2079256064 hasRelatedWork W3164545216 @default.
W2079256064 hasRelatedWork W4247718175 @default.
W2079256064 hasVolume "59" @default.
W2079256064 isParatext "false" @default.
W2079256064 isRetracted "false" @default.
W2079256064 magId "2079256064" @default.
W2079256064 workType "article" @default.